Advanced search×

A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension.

I Goldberg, X-Y Li, P Selaru, and D Paggiarino

Eur J Ophthalmol 18(3):408-16 (2008) PMID 18465724

To investigate the incidence of latanoprost-related adverse events of the cornea, iris, and retina and the occurrence of hyperpigmentation.

Version: za2963e q8za1 q8zb4 q8zc7 q8zd1 q8ze2 q8zff q8zg4

Similar articles you may find interesting…

  1. Three-dimensional localisation versus fluoroscopically-only guided ablations: A meta-analysis.
    Mohammed Shurrab, Avishag Laish-Farkash, and Eugene Crystal

    Scand Cardiovasc J (2013) PMID 23647246

    Success, procedure time, and complications were similar between fluoroscopic and 3D-guided ablations. Fluoroscopic time and RD were significantly reduced for ablation of AFL and SVT with 3D....
  2. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
    Emma Yue Zhang, Massimo Cristofanilli, and William S Hancock

    J Proteome Res (2013) PMID 23647160

    We selected three breast cancer cell lines (SKBR3, SUM149 and SUM190) with different oncogene expression levels involved in ERBB2 and EGFR signaling pathways as a model system for the evaluation of selective integration of subsets of transcriptomic and proteomic data. We assessed the oncogene status...
  3. Endothelial Shc Regulates Arteriogenesis Through Dual Control of Arterial Specification and Inflammation via the Notch and NF-κB Pathways.
    Daniel T Sweet, Zhongming Chen, and Ellie Tzima

    Circ Res (2013) PMID 23661718

    Shc mediates activation of two key signaling pathways that are critical for inflammation and arterial specification; collectively, these pathways contribute to arteriogenesis and recovery of blood perfusion....